Prematurity (Preterm Birth) – Overview
Preterm birth = live birth <37 weeks of gestation
Preterm severity classification: [Ref]
| Classification | Gestational age |
|---|---|
| Moderate to late preterm | 32 – 36+6 weeks |
| Very preterm | 28 – 31+6 weeks |
| Extremely preterm | <28 weeks |
Note: This article covers prematurity from a neonatal / paediatric perspective.
For obstetric assessment and management of preterm labour and birth, see the separate PROM, P-PROM, and Preterm Labour article.
Complications of prematurity (preterm birth) by body system.
Respiratory
Respiratory complications are particularly important in preterm infants and are covered in greater detail in the separate Respiratory Complications of Prematurity article.
| Complication | Pathophysiology | Recognition | Management principle |
|---|---|---|---|
| Neonatal respiratory distress syndrome (NRDS) [Ref] | Surfactant deficiency → alveolar collapse and reduced lung compliance | Respiratory distress soon after birth (e.g. tachypnoea, grunting, recession and increasing oxygen requirement) | Respiratory support +/- exogenous surfactant |
| Apnoea of prematurity [Ref] | Immature brainstem respiratory centre → apnoea | Recurrent apnoea +/- bradycardia, hypoxia | Caffeine citrate +/- respiratory support |
| Bronchopulmonary dysplasia (BPD) (chronic lung disease of prematurity) [Ref1][Ref2] | Immature lungs exposed to ventilation / oxygen / inflammation → chronic lung disease | Persistent oxygen and/or respiratory-support requirement | Minimise ongoing lung injury + respiratory support as needed |
For infants requiring oxygen therapy after initial stabilisation, target SpO2 91-95% to balance the risks of hyperoxia and hypoxia. [NICE NG124]
Excess oxygen exposure is associated with increased risk of retinopathy of prematurity and bronchopulmonary dysplasia.
Cardiovascular
Key cardiovascular complication of prematurity is patent ductus arteriosus (PDA)
| Pathophysiology [Ref] | Normal role of ductus arteriosus:
In preterm infants, the ductus arteriosus is more likely to remain patent due to the following factors:
If the ductus arteriosus remains patent in an infant → left to right shunt which results in:
|
| Clinical features [Ref1][Ref2] | Typical features of PDA in a preterm infant
|
| Investigation and diagnosis [Ref] | Confirmatory test: echocardiography
Echo is also used to determine whether PDA is haemodynamically significant, to guide management |
| Management [Ref1][Ref2] |
Do NOT routinely treat all PDA in preterm infants. Routine early closure has not clearly improved important long-term outcomes. Active management should only be considered if there is a haemodynamically significant PDA, indicated by:
Choice of management:
|
Metabolic
Key metabolic complications in a preterm infant: [Ref]
| Complication | Pathophysiology | Recognition / key points |
|---|---|---|
| Hypoglycaemia | ↓ Glycogen and fat stores
Glycogen synthesis and fat deposition occur primarily during the 3rd trimester. Preterm infants are born before these stores build up |
May be asymptomatic
If symptomatic:
Also see the Neonatal Hypoglycaemia article |
| Hyperbilirubinaemia / neonatal jaundice | Immature hepatic conjugation and excretion | Jaundice may develop earlier or be more significant
Preterm infants are more vulnerable to bilirubin neurotoxicity Also see the Neonatal Jaundice article |
| Hypothermia | Preterm infants have ↑ heat loss due to
|
Possible features:
|
Gastrointestinal (GI)
Key GI complications in preterm infants:
| Complication | Pathophysiology | Recognition | Management principles |
|---|---|---|---|
| Necrotising enterocolitis (NEC) [Ref]
NEC is covered in more details in a separate article |
Immature intestinal barrier + dysregulated inflammatory response and abnormal microbial colonisation → intestinal inflammation and injury
May progress to necrosis and perforation |
|
Antenatal corticosteroids in pre-term delivery reduces risk of NEC, beyond its benefit in reducing NRDS and IVH. [Ref] |
| Feeding intolerance [Ref] | Immature sucking + small stomach + immature gastrointestinal motility |
|
Note that worsening feeding intolerance may be an early sign of necrotising enterocolitis |
Ophthalmological
Key complication is retinopathy of prematurity (ROP):
| Pathophysiology [Ref] |
|
| Clinical features [Ref] | Usually asymptomatic initially
|
| Screening [RCPCH] | Indications for screening:
Screening technique:
|
| Prevention | Preventive measures: [NICE NG124]
Screening for ROP: [RCPCH]
|
| Management [RCOphth] | Active management options for established ROP:
|
Neurological
2 most important preterm related brain injuries:
| Complication | Pathophysiology | Clinical manifestation |
|---|---|---|
| Intraventricular haemorrhage (IVH) [Ref] | Fragile vessels in the germinal matrix of the premature brain are prone to rupture
Bleeding may remain within the germinal matrix or extend into the ventricles |
Mostly asymptomatic (esp. with low-grade haemorrhage)
If symptomatic:
More severe IVH can cause post-haemorrhagic hydrocephalus → raised ICP |
| Periventricular leukomalacia (PVL) [Ref] | Hypoxic-ischaemic and inflammatory injury to vulnerable periventricular white matter
Results in white matter necrosis and impaired myelination |
PVL typically contributes to later, long-term neurodevelopmental complications (instead of acute complications) |
Shared information: [Ref]
- Imaging:
- 1st line: cranial ultrasound
- 2nd line: MRI
- Routine cranial ultrasound surveillance is standard practice in very preterm infants (<32 weeks) [NHS GGC]
- Early scans (day 1, 3 7) are used to detect IVH
- Later scans (day 28) are used to detect PVL
- There is no specific curative treatment for IVH and PVL, management is largely supportive + monitoring for complications
Antenatal corticosteroids in pre-term delivery reduces risk of IVH, beyond its benefit in reducing NRDS and NEC. [Ref]
Long-term neurodevelopmental consequences (IVH and PVL are major independent risk factors): [NICE NG72]
- Cerebral palsy and motor impairment
- Cognitive and learning difficulties (including global developmental delay, intellectual disability, special education needs, lower education attainment)
- Speech, language and executive-function problems
- Behavioural and neurodevelopmental disorders (including ADHD, ASD)
- Sensory impairment (including visual and hearing impairment)
In preterm birth, antenatal IV magnesium sulfate is recommended to reduce the risk of cerebral palsy.